nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—ABCC3—Glyburide—gestational diabetes	0.214	0.279	CbGbCtD
Doxorubicin—ABCB11—Glyburide—gestational diabetes	0.185	0.241	CbGbCtD
Doxorubicin—ABCC1—Glyburide—gestational diabetes	0.131	0.171	CbGbCtD
Doxorubicin—ABCC2—Glyburide—gestational diabetes	0.0971	0.127	CbGbCtD
Doxorubicin—ABCG2—Glyburide—gestational diabetes	0.0878	0.115	CbGbCtD
Doxorubicin—ABCB1—Glyburide—gestational diabetes	0.0317	0.0414	CbGbCtD
Doxorubicin—CYP3A4—Glyburide—gestational diabetes	0.019	0.0248	CbGbCtD
Doxorubicin—NOS3—tunica intima—gestational diabetes	0.0109	0.0859	CbGeAlD
Doxorubicin—Lactic acidosis—Glyburide—gestational diabetes	0.00737	0.103	CcSEcCtD
Doxorubicin—NOS3—umbilical vein—gestational diabetes	0.00666	0.0524	CbGeAlD
Doxorubicin—CBR3—embryo—gestational diabetes	0.0039	0.0307	CbGeAlD
Doxorubicin—Myelosuppression—Glyburide—gestational diabetes	0.00384	0.0536	CcSEcCtD
Doxorubicin—Kidney function abnormal—Glyburide—gestational diabetes	0.00372	0.052	CcSEcCtD
Doxorubicin—Blindness—Glyburide—gestational diabetes	0.00325	0.0454	CcSEcCtD
Doxorubicin—AKR1A1—islet of Langerhans—gestational diabetes	0.00311	0.0245	CbGeAlD
Doxorubicin—Eruption—Glyburide—gestational diabetes	0.00292	0.0409	CcSEcCtD
Doxorubicin—NDUFS7—islet of Langerhans—gestational diabetes	0.00283	0.0223	CbGeAlD
Doxorubicin—ABCB8—adipose tissue—gestational diabetes	0.00267	0.021	CbGeAlD
Doxorubicin—CBR3—adipose tissue—gestational diabetes	0.00257	0.0203	CbGeAlD
Doxorubicin—NDUFS2—islet of Langerhans—gestational diabetes	0.00235	0.0185	CbGeAlD
Doxorubicin—NDUFS3—islet of Langerhans—gestational diabetes	0.00232	0.0182	CbGeAlD
Doxorubicin—DHCR7—islet of Langerhans—gestational diabetes	0.0022	0.0173	CbGeAlD
Doxorubicin—CBR3—vagina—gestational diabetes	0.00214	0.0168	CbGeAlD
Doxorubicin—ABCB8—head—gestational diabetes	0.00205	0.0162	CbGeAlD
Doxorubicin—Jaundice cholestatic—Glyburide—gestational diabetes	0.00205	0.0286	CcSEcCtD
Doxorubicin—AKR1A1—uterus—gestational diabetes	0.00203	0.016	CbGeAlD
Doxorubicin—YWHAG—islet of Langerhans—gestational diabetes	0.00202	0.0159	CbGeAlD
Doxorubicin—AKR1A1—adipose tissue—gestational diabetes	0.00199	0.0156	CbGeAlD
Doxorubicin—Hyperbilirubinaemia—Glyburide—gestational diabetes	0.00198	0.0276	CcSEcCtD
Doxorubicin—CBR3—head—gestational diabetes	0.00198	0.0156	CbGeAlD
Doxorubicin—RALBP1—islet of Langerhans—gestational diabetes	0.00182	0.0144	CbGeAlD
Doxorubicin—NDUFS7—adipose tissue—gestational diabetes	0.00181	0.0142	CbGeAlD
Doxorubicin—AURKA—uterus—gestational diabetes	0.00172	0.0135	CbGeAlD
Doxorubicin—CBR1—islet of Langerhans—gestational diabetes	0.0017	0.0134	CbGeAlD
Doxorubicin—Aplastic anaemia—Glyburide—gestational diabetes	0.00169	0.0236	CcSEcCtD
Doxorubicin—AKR1C3—islet of Langerhans—gestational diabetes	0.00168	0.0132	CbGeAlD
Doxorubicin—AKR1A1—vagina—gestational diabetes	0.00165	0.013	CbGeAlD
Doxorubicin—POR—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.00163	0.0448	CbGpPWpGaD
Doxorubicin—POR—islet of Langerhans—gestational diabetes	0.00154	0.0121	CbGeAlD
Doxorubicin—NDUFS2—uterus—gestational diabetes	0.00153	0.012	CbGeAlD
Doxorubicin—AKR1A1—head—gestational diabetes	0.00153	0.012	CbGeAlD
Doxorubicin—NDUFS3—uterus—gestational diabetes	0.00151	0.0119	CbGeAlD
Doxorubicin—NDUFS7—vagina—gestational diabetes	0.0015	0.0118	CbGeAlD
Doxorubicin—NDUFS2—adipose tissue—gestational diabetes	0.0015	0.0118	CbGeAlD
Doxorubicin—Hepatic function abnormal—Glyburide—gestational diabetes	0.00149	0.0209	CcSEcCtD
Doxorubicin—NDUFS3—adipose tissue—gestational diabetes	0.00148	0.0116	CbGeAlD
Doxorubicin—Vascular purpura—Glyburide—gestational diabetes	0.00146	0.0204	CcSEcCtD
Doxorubicin—Hepatic failure—Glyburide—gestational diabetes	0.00145	0.0203	CcSEcCtD
Doxorubicin—Renal failure acute—Glyburide—gestational diabetes	0.00141	0.0198	CcSEcCtD
Doxorubicin—DHCR7—adipose tissue—gestational diabetes	0.0014	0.0111	CbGeAlD
Doxorubicin—AURKA—vagina—gestational diabetes	0.0014	0.011	CbGeAlD
Doxorubicin—NDUFS7—head—gestational diabetes	0.00139	0.0109	CbGeAlD
Doxorubicin—Renal impairment—Glyburide—gestational diabetes	0.00137	0.0192	CcSEcCtD
Doxorubicin—ABCC6—adipose tissue—gestational diabetes	0.00137	0.0108	CbGeAlD
Doxorubicin—Dermatitis bullous—Glyburide—gestational diabetes	0.00137	0.0191	CcSEcCtD
Doxorubicin—NQO1—islet of Langerhans—gestational diabetes	0.00136	0.0107	CbGeAlD
Doxorubicin—Purpura—Glyburide—gestational diabetes	0.00135	0.0189	CcSEcCtD
Doxorubicin—Hypoglycaemia—Glyburide—gestational diabetes	0.00134	0.0187	CcSEcCtD
Doxorubicin—YWHAG—uterus—gestational diabetes	0.00132	0.0104	CbGeAlD
Doxorubicin—Hyponatraemia—Glyburide—gestational diabetes	0.00131	0.0183	CcSEcCtD
Doxorubicin—Diplopia—Glyburide—gestational diabetes	0.00131	0.0182	CcSEcCtD
Doxorubicin—AURKA—head—gestational diabetes	0.00129	0.0101	CbGeAlD
Doxorubicin—YWHAG—adipose tissue—gestational diabetes	0.00129	0.0101	CbGeAlD
Doxorubicin—AKR1C3—Retinoid metabolism and transport—RBP4—gestational diabetes	0.00128	0.0353	CbGpPWpGaD
Doxorubicin—AKR1A1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00128	0.0352	CbGpPWpGaD
Doxorubicin—NDUFS2—vagina—gestational diabetes	0.00124	0.00979	CbGeAlD
Doxorubicin—NDUFS3—vagina—gestational diabetes	0.00123	0.00967	CbGeAlD
Doxorubicin—RALBP1—uterus—gestational diabetes	0.00119	0.00936	CbGeAlD
Doxorubicin—DHCR7—vagina—gestational diabetes	0.00117	0.00919	CbGeAlD
Doxorubicin—RALBP1—adipose tissue—gestational diabetes	0.00116	0.00916	CbGeAlD
Doxorubicin—NOS1—head—gestational diabetes	0.00116	0.0091	CbGeAlD
Doxorubicin—NDUFS2—head—gestational diabetes	0.00115	0.00904	CbGeAlD
Doxorubicin—Abdominal distension—Glyburide—gestational diabetes	0.00114	0.0159	CcSEcCtD
Doxorubicin—NDUFS3—head—gestational diabetes	0.00113	0.00893	CbGeAlD
Doxorubicin—Eosinophilia—Glyburide—gestational diabetes	0.00112	0.0156	CcSEcCtD
Doxorubicin—CBR1—uterus—gestational diabetes	0.00111	0.00874	CbGeAlD
Doxorubicin—Pancreatitis—Glyburide—gestational diabetes	0.00111	0.0155	CcSEcCtD
Doxorubicin—AKR1C3—uterus—gestational diabetes	0.0011	0.00863	CbGeAlD
Doxorubicin—CBR1—adipose tissue—gestational diabetes	0.00109	0.00855	CbGeAlD
Doxorubicin—DHCR7—head—gestational diabetes	0.00108	0.00849	CbGeAlD
Doxorubicin—AKR1C3—adipose tissue—gestational diabetes	0.00107	0.00844	CbGeAlD
Doxorubicin—Pancytopenia—Glyburide—gestational diabetes	0.00107	0.015	CcSEcCtD
Doxorubicin—YWHAG—vagina—gestational diabetes	0.00107	0.00843	CbGeAlD
Doxorubicin—ABCC6—head—gestational diabetes	0.00105	0.00827	CbGeAlD
Doxorubicin—XDH—vagina—gestational diabetes	0.00104	0.00822	CbGeAlD
Doxorubicin—Photosensitivity reaction—Glyburide—gestational diabetes	0.00103	0.0144	CcSEcCtD
Doxorubicin—YWHAG—head—gestational diabetes	0.000989	0.00779	CbGeAlD
Doxorubicin—Jaundice—Glyburide—gestational diabetes	0.000981	0.0137	CcSEcCtD
Doxorubicin—POR—adipose tissue—gestational diabetes	0.00098	0.00771	CbGeAlD
Doxorubicin—RALBP1—vagina—gestational diabetes	0.000967	0.00761	CbGeAlD
Doxorubicin—NOS3—vagina—gestational diabetes	0.000952	0.00749	CbGeAlD
Doxorubicin—Agranulocytosis—Glyburide—gestational diabetes	0.000939	0.0131	CcSEcCtD
Doxorubicin—TOP2A—uterus—gestational diabetes	0.000934	0.00735	CbGeAlD
Doxorubicin—TOP2A—adipose tissue—gestational diabetes	0.000913	0.00719	CbGeAlD
Doxorubicin—Hepatitis—Glyburide—gestational diabetes	0.000903	0.0126	CcSEcCtD
Doxorubicin—CBR1—vagina—gestational diabetes	0.000903	0.00711	CbGeAlD
Doxorubicin—RALBP1—head—gestational diabetes	0.000893	0.00703	CbGeAlD
Doxorubicin—AKR1C3—vagina—gestational diabetes	0.000892	0.00702	CbGeAlD
Doxorubicin—NQO1—uterus—gestational diabetes	0.00089	0.007	CbGeAlD
Doxorubicin—NOS3—head—gestational diabetes	0.000879	0.00692	CbGeAlD
Doxorubicin—Visual impairment—Glyburide—gestational diabetes	0.000871	0.0122	CcSEcCtD
Doxorubicin—NQO1—adipose tissue—gestational diabetes	0.00087	0.00685	CbGeAlD
Doxorubicin—NOS3—Leptin signaling pathway—LEPR—gestational diabetes	0.000868	0.0239	CbGpPWpGaD
Doxorubicin—NOS2—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.00085	0.0234	CbGpPWpGaD
Doxorubicin—Eye disorder—Glyburide—gestational diabetes	0.000844	0.0118	CcSEcCtD
Doxorubicin—CBR1—head—gestational diabetes	0.000834	0.00656	CbGeAlD
Doxorubicin—POR—vagina—gestational diabetes	0.000814	0.00641	CbGeAlD
Doxorubicin—Alopecia—Glyburide—gestational diabetes	0.000798	0.0112	CcSEcCtD
Doxorubicin—ABCC10—uterus—gestational diabetes	0.000795	0.00625	CbGeAlD
Doxorubicin—Malnutrition—Glyburide—gestational diabetes	0.000786	0.011	CcSEcCtD
Doxorubicin—Erythema—Glyburide—gestational diabetes	0.000786	0.011	CcSEcCtD
Doxorubicin—ABCC3—adipose tissue—gestational diabetes	0.000781	0.00615	CbGeAlD
Doxorubicin—ABCC10—adipose tissue—gestational diabetes	0.000777	0.00612	CbGeAlD
Doxorubicin—TOP2A—vagina—gestational diabetes	0.000759	0.00597	CbGeAlD
Doxorubicin—Vision blurred—Glyburide—gestational diabetes	0.000741	0.0104	CcSEcCtD
Doxorubicin—Anaemia—Glyburide—gestational diabetes	0.000727	0.0102	CcSEcCtD
Doxorubicin—NQO1—vagina—gestational diabetes	0.000723	0.00569	CbGeAlD
Doxorubicin—Leukopenia—Glyburide—gestational diabetes	0.000704	0.00984	CcSEcCtD
Doxorubicin—Convulsion—Glyburide—gestational diabetes	0.000681	0.00952	CcSEcCtD
Doxorubicin—Myalgia—Glyburide—gestational diabetes	0.000669	0.00936	CcSEcCtD
Doxorubicin—Arthralgia—Glyburide—gestational diabetes	0.000669	0.00936	CcSEcCtD
Doxorubicin—NQO1—head—gestational diabetes	0.000668	0.00526	CbGeAlD
Doxorubicin—SLC22A16—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000668	0.0184	CbGpPWpGaD
Doxorubicin—CYP1B1—Endogenous sterols—CYP19A1—gestational diabetes	0.000661	0.0182	CbGpPWpGaD
Doxorubicin—AKR1C3—Diseases associated with visual transduction—RBP4—gestational diabetes	0.000655	0.018	CbGpPWpGaD
Doxorubicin—Confusional state—Glyburide—gestational diabetes	0.000647	0.00904	CcSEcCtD
Doxorubicin—ABCC10—vagina—gestational diabetes	0.000646	0.00509	CbGeAlD
Doxorubicin—NQO1—Amino acid and derivative metabolism—GLS2—gestational diabetes	0.000644	0.0177	CbGpPWpGaD
Doxorubicin—Oedema—Glyburide—gestational diabetes	0.000642	0.00897	CcSEcCtD
Doxorubicin—Shock—Glyburide—gestational diabetes	0.000631	0.00882	CcSEcCtD
Doxorubicin—Nervous system disorder—Glyburide—gestational diabetes	0.000629	0.0088	CcSEcCtD
Doxorubicin—Thrombocytopenia—Glyburide—gestational diabetes	0.000628	0.00878	CcSEcCtD
Doxorubicin—CYP1B1—uterus—gestational diabetes	0.000625	0.00492	CbGeAlD
Doxorubicin—Hyperhidrosis—Glyburide—gestational diabetes	0.00062	0.00867	CcSEcCtD
Doxorubicin—Anorexia—Glyburide—gestational diabetes	0.000612	0.00855	CcSEcCtD
Doxorubicin—CYP1B1—adipose tissue—gestational diabetes	0.000611	0.00481	CbGeAlD
Doxorubicin—ABCC3—head—gestational diabetes	0.0006	0.00472	CbGeAlD
Doxorubicin—Hypotension—Glyburide—gestational diabetes	0.0006	0.00838	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.000585	0.00817	CcSEcCtD
Doxorubicin—Paraesthesia—Glyburide—gestational diabetes	0.000576	0.00805	CcSEcCtD
Doxorubicin—NOS3—Angiogenesis—FGF2—gestational diabetes	0.000576	0.0159	CbGpPWpGaD
Doxorubicin—Dyspnoea—Glyburide—gestational diabetes	0.000572	0.008	CcSEcCtD
Doxorubicin—Dyspepsia—Glyburide—gestational diabetes	0.000565	0.00789	CcSEcCtD
Doxorubicin—ABCC1—uterus—gestational diabetes	0.000562	0.00442	CbGeAlD
Doxorubicin—Decreased appetite—Glyburide—gestational diabetes	0.000558	0.0078	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000554	0.00774	CcSEcCtD
Doxorubicin—ABCC1—adipose tissue—gestational diabetes	0.00055	0.00433	CbGeAlD
Doxorubicin—ABCB8—Transmembrane transport of small molecules—GCK—gestational diabetes	0.00055	0.0151	CbGpPWpGaD
Doxorubicin—Feeling abnormal—Glyburide—gestational diabetes	0.000529	0.00739	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Glyburide—gestational diabetes	0.000525	0.00733	CcSEcCtD
Doxorubicin—Urticaria—Glyburide—gestational diabetes	0.00051	0.00712	CcSEcCtD
Doxorubicin—Abdominal pain—Glyburide—gestational diabetes	0.000507	0.00709	CcSEcCtD
Doxorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—AR—gestational diabetes	0.000507	0.014	CbGpPWpGaD
Doxorubicin—NOS1—Monoamine Transport—TNF—gestational diabetes	0.000476	0.0131	CbGpPWpGaD
Doxorubicin—Hypersensitivity—Glyburide—gestational diabetes	0.000473	0.00661	CcSEcCtD
Doxorubicin—CYP1B1—head—gestational diabetes	0.000469	0.00369	CbGeAlD
Doxorubicin—ABCG2—uterus—gestational diabetes	0.000465	0.00366	CbGeAlD
Doxorubicin—Asthenia—Glyburide—gestational diabetes	0.00046	0.00643	CcSEcCtD
Doxorubicin—ABCC1—vagina—gestational diabetes	0.000457	0.0036	CbGeAlD
Doxorubicin—ABCG2—adipose tissue—gestational diabetes	0.000455	0.00358	CbGeAlD
Doxorubicin—Pruritus—Glyburide—gestational diabetes	0.000454	0.00635	CcSEcCtD
Doxorubicin—Diarrhoea—Glyburide—gestational diabetes	0.000439	0.00614	CcSEcCtD
Doxorubicin—NOS2—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000435	0.012	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.000418	0.0115	CbGpPWpGaD
Doxorubicin—NOS1—Amyotrophic lateral sclerosis (ALS)—TNF—gestational diabetes	0.000415	0.0114	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.000413	0.0114	CbGpPWpGaD
Doxorubicin—Vomiting—Glyburide—gestational diabetes	0.000408	0.0057	CcSEcCtD
Doxorubicin—Rash—Glyburide—gestational diabetes	0.000405	0.00565	CcSEcCtD
Doxorubicin—Dermatitis—Glyburide—gestational diabetes	0.000404	0.00565	CcSEcCtD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.000402	0.0111	CbGpPWpGaD
Doxorubicin—Headache—Glyburide—gestational diabetes	0.000402	0.00562	CcSEcCtD
Doxorubicin—NOS2—Circadian rythm related genes—MTNR1B—gestational diabetes	0.000402	0.0111	CbGpPWpGaD
Doxorubicin—Nausea—Glyburide—gestational diabetes	0.000381	0.00533	CcSEcCtD
Doxorubicin—CYP1B1—Biological oxidations—GGCT—gestational diabetes	0.00038	0.0105	CbGpPWpGaD
Doxorubicin—CYP1B1—Tryptophan metabolism—CYP19A1—gestational diabetes	0.00038	0.0105	CbGpPWpGaD
Doxorubicin—ABCG2—vagina—gestational diabetes	0.000378	0.00298	CbGeAlD
Doxorubicin—NOS1—Spinal Cord Injury—LEP—gestational diabetes	0.000362	0.00998	CbGpPWpGaD
Doxorubicin—ABCG2—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000354	0.00975	CbGpPWpGaD
Doxorubicin—ABCB1—islet of Langerhans—gestational diabetes	0.000352	0.00277	CbGeAlD
Doxorubicin—NOS2—Circadian rythm related genes—NAMPT—gestational diabetes	0.000351	0.00967	CbGpPWpGaD
Doxorubicin—CYP2B6—vagina—gestational diabetes	0.000349	0.00275	CbGeAlD
Doxorubicin—ABCB1—embryo—gestational diabetes	0.00034	0.00268	CbGeAlD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—GCK—gestational diabetes	0.00034	0.00935	CbGpPWpGaD
Doxorubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—gestational diabetes	0.000325	0.00894	CbGpPWpGaD
Doxorubicin—CYP2B6—head—gestational diabetes	0.000322	0.00254	CbGeAlD
Doxorubicin—NOS3—Angiopoietin receptor Tie2-mediated signaling—FGF2—gestational diabetes	0.00032	0.00882	CbGpPWpGaD
Doxorubicin—NOS2—IL23-mediated signaling events—TNF—gestational diabetes	0.00032	0.0088	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—GGCT—gestational diabetes	0.000311	0.00856	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—GGCT—gestational diabetes	0.000311	0.00856	CbGpPWpGaD
Doxorubicin—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000307	0.00846	CbGpPWpGaD
Doxorubicin—NOS3—Leptin signaling pathway—LEP—gestational diabetes	0.000305	0.0084	CbGpPWpGaD
Doxorubicin—CYP1B1—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000303	0.00834	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000297	0.00818	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—GGCT—gestational diabetes	0.000292	0.00805	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.000287	0.00791	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—MTNR1B—gestational diabetes	0.000275	0.00756	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—LEP—gestational diabetes	0.000273	0.00753	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—GLS2—gestational diabetes	0.000272	0.00748	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—GLS2—gestational diabetes	0.000272	0.00748	CbGpPWpGaD
Doxorubicin—AKR1C3—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000262	0.00721	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000257	0.00709	CbGpPWpGaD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000256	0.00704	CbGpPWpGaD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000256	0.00704	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—GLS2—gestational diabetes	0.000255	0.00703	CbGpPWpGaD
Doxorubicin—CYP2B6—Biological oxidations—GGCT—gestational diabetes	0.000253	0.00698	CbGpPWpGaD
Doxorubicin—CYP1B1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000249	0.00686	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—GGCT—gestational diabetes	0.000248	0.00684	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—NAMPT—gestational diabetes	0.00024	0.00661	CbGpPWpGaD
Doxorubicin—CYP2D6—head—gestational diabetes	0.00024	0.00189	CbGeAlD
Doxorubicin—CBR1—Metabolism—GGCT—gestational diabetes	0.000232	0.00638	CbGpPWpGaD
Doxorubicin—NOS1—Alzheimers Disease—TNF—gestational diabetes	0.000231	0.00636	CbGpPWpGaD
Doxorubicin—ABCB1—uterus—gestational diabetes	0.000229	0.00181	CbGeAlD
Doxorubicin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—gestational diabetes	0.000228	0.00629	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000225	0.0062	CbGpPWpGaD
Doxorubicin—ABCB1—adipose tissue—gestational diabetes	0.000224	0.00177	CbGeAlD
Doxorubicin—DHCR7—Metabolism—GLS2—gestational diabetes	0.000217	0.00598	CbGpPWpGaD
Doxorubicin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000205	0.00564	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—GLS2—gestational diabetes	0.000202	0.00558	CbGpPWpGaD
Doxorubicin—CYP2B6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000202	0.00557	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.000196	0.00541	CbGpPWpGaD
Doxorubicin—NOS3—Angiopoietin receptor Tie2-mediated signaling—TNF—gestational diabetes	0.000195	0.00537	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000194	0.00535	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000191	0.00527	CbGpPWpGaD
Doxorubicin—ABCB1—vagina—gestational diabetes	0.000187	0.00147	CbGeAlD
Doxorubicin—ABCG2—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000181	0.00499	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000181	0.00499	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—LEP—gestational diabetes	0.000178	0.00491	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000177	0.00487	CbGpPWpGaD
Doxorubicin—CYP2D6—Biological oxidations—GGCT—gestational diabetes	0.000176	0.00485	CbGpPWpGaD
Doxorubicin—ABCB1—head—gestational diabetes	0.000172	0.00136	CbGeAlD
Doxorubicin—NOS1—Spinal Cord Injury—TNF—gestational diabetes	0.000168	0.00461	CbGpPWpGaD
Doxorubicin—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000166	0.00457	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—NAMPT—gestational diabetes	0.000149	0.0041	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—NAMPT—gestational diabetes	0.000149	0.0041	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—GCK—gestational diabetes	0.000148	0.00407	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—GCK—gestational diabetes	0.000148	0.00407	CbGpPWpGaD
Doxorubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000142	0.00392	CbGpPWpGaD
Doxorubicin—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.00014	0.00387	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—NAMPT—gestational diabetes	0.00014	0.00385	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—GCK—gestational diabetes	0.000139	0.00383	CbGpPWpGaD
Doxorubicin—XDH—Selenium Micronutrient Network—TNF—gestational diabetes	0.000137	0.00376	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—LEPR—gestational diabetes	0.000136	0.00376	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GGCT—gestational diabetes	0.000135	0.00372	CbGpPWpGaD
Doxorubicin—CYP1B1—Biological oxidations—CYP19A1—gestational diabetes	0.000132	0.00364	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GGCT—gestational diabetes	0.00013	0.00359	CbGpPWpGaD
Doxorubicin—CYP1B1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00013	0.00359	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—TNF—gestational diabetes	0.000126	0.00348	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.000123	0.00338	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000123	0.00338	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—LEP—gestational diabetes	0.000122	0.00336	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GGCT—gestational diabetes	0.000121	0.00334	CbGpPWpGaD
Doxorubicin—NOS1—Disease—RBP4—gestational diabetes	0.00012	0.00331	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—NAMPT—gestational diabetes	0.000119	0.00328	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GLS2—gestational diabetes	0.000118	0.00326	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—GCK—gestational diabetes	0.000118	0.00326	CbGpPWpGaD
Doxorubicin—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000115	0.00318	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.000115	0.00317	CbGpPWpGaD
Doxorubicin—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000115	0.00317	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GLS2—gestational diabetes	0.000114	0.00314	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—NAMPT—gestational diabetes	0.000111	0.00306	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—GCK—gestational diabetes	0.00011	0.00304	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GGCT—gestational diabetes	0.00011	0.00304	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—CYP19A1—gestational diabetes	0.000108	0.00298	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—CYP19A1—gestational diabetes	0.000108	0.00298	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MTNR1B—gestational diabetes	0.000108	0.00297	CbGpPWpGaD
Doxorubicin—NOS1—Disease—NAMPT—gestational diabetes	0.000108	0.00296	CbGpPWpGaD
Doxorubicin—NOS1—Disease—GCK—gestational diabetes	0.000107	0.00295	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GLS2—gestational diabetes	0.000106	0.00292	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—RBP4—gestational diabetes	0.000105	0.0029	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000102	0.00281	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—CYP19A1—gestational diabetes	0.000102	0.0028	CbGpPWpGaD
Doxorubicin—YWHAG—Apoptosis—TNF—gestational diabetes	9.93e-05	0.00274	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—TNF—gestational diabetes	9.88e-05	0.00272	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	9.79e-05	0.0027	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	9.65e-05	0.00266	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GLS2—gestational diabetes	9.64e-05	0.00265	CbGpPWpGaD
Doxorubicin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	9.3e-05	0.00256	CbGpPWpGaD
Doxorubicin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	9.18e-05	0.00253	CbGpPWpGaD
Doxorubicin—NOS2—Disease—RBP4—gestational diabetes	9.05e-05	0.00249	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GGCT—gestational diabetes	8.94e-05	0.00246	CbGpPWpGaD
Doxorubicin—CYP2B6—Biological oxidations—CYP19A1—gestational diabetes	8.82e-05	0.00243	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—GCK—gestational diabetes	8.71e-05	0.0024	CbGpPWpGaD
Doxorubicin—CYP2B6—Metapathway biotransformation—CYP19A1—gestational diabetes	8.7e-05	0.0024	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—CYP19A1—gestational diabetes	8.64e-05	0.00238	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GGCT—gestational diabetes	8.57e-05	0.00236	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—RBP4—gestational diabetes	8.32e-05	0.00229	CbGpPWpGaD
Doxorubicin—NOS2—Disease—NAMPT—gestational diabetes	8.12e-05	0.00224	CbGpPWpGaD
Doxorubicin—NOS2—Disease—GCK—gestational diabetes	8.07e-05	0.00222	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—CYP19A1—gestational diabetes	8.06e-05	0.00222	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GLS2—gestational diabetes	7.82e-05	0.00215	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—LEPR—gestational diabetes	7.56e-05	0.00208	CbGpPWpGaD
Doxorubicin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	7.54e-05	0.00208	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GLS2—gestational diabetes	7.49e-05	0.00206	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NAMPT—gestational diabetes	7.46e-05	0.00206	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—GCK—gestational diabetes	7.41e-05	0.00204	CbGpPWpGaD
Doxorubicin—NOS3—Disease—RBP4—gestational diabetes	7.03e-05	0.00194	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	6.99e-05	0.00192	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—GCK—gestational diabetes	6.91e-05	0.0019	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—GCK—gestational diabetes	6.83e-05	0.00188	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GGCT—gestational diabetes	6.72e-05	0.00185	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	6.7e-05	0.00185	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GGCT—gestational diabetes	6.5e-05	0.00179	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—NAMPT—gestational diabetes	6.48e-05	0.00178	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GCK—gestational diabetes	6.44e-05	0.00177	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—LEPR—gestational diabetes	6.39e-05	0.00176	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NAMPT—gestational diabetes	6.3e-05	0.00174	CbGpPWpGaD
Doxorubicin—NOS3—Disease—GCK—gestational diabetes	6.26e-05	0.00173	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—NAMPT—gestational diabetes	6.25e-05	0.00172	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GCK—gestational diabetes	6.21e-05	0.00171	CbGpPWpGaD
Doxorubicin—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	6.13e-05	0.00169	CbGpPWpGaD
Doxorubicin—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	6.04e-05	0.00166	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—GCK—gestational diabetes	6.01e-05	0.00165	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MTNR1B—gestational diabetes	5.98e-05	0.00165	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GGCT—gestational diabetes	5.91e-05	0.00163	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	5.88e-05	0.00162	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GLS2—gestational diabetes	5.87e-05	0.00162	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RBP4—gestational diabetes	5.83e-05	0.0016	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	5.82e-05	0.0016	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—NAMPT—gestational diabetes	5.81e-05	0.0016	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GCK—gestational diabetes	5.77e-05	0.00159	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GLS2—gestational diabetes	5.68e-05	0.00156	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—NAMPT—gestational diabetes	5.28e-05	0.00145	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.25e-05	0.00145	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GCK—gestational diabetes	5.25e-05	0.00145	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GLS2—gestational diabetes	5.17e-05	0.00142	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.08e-05	0.0014	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MTNR1B—gestational diabetes	5.05e-05	0.00139	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RBP4—gestational diabetes	4.92e-05	0.00136	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—LEP—gestational diabetes	4.79e-05	0.00132	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CYP19A1—gestational diabetes	4.71e-05	0.0013	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CYP19A1—gestational diabetes	4.54e-05	0.00125	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GGCT—gestational diabetes	4.33e-05	0.00119	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—RBP4—gestational diabetes	4.28e-05	0.00118	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—NAMPT—gestational diabetes	4.28e-05	0.00118	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GCK—gestational diabetes	4.26e-05	0.00117	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CYP19A1—gestational diabetes	4.22e-05	0.00116	CbGpPWpGaD
Doxorubicin—NOS1—Disease—FGF2—gestational diabetes	4.16e-05	0.00114	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—NAMPT—gestational diabetes	4.11e-05	0.00113	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GCK—gestational diabetes	4.08e-05	0.00112	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	4.01e-05	0.0011	CbGpPWpGaD
Doxorubicin—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	3.95e-05	0.00109	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TNF—gestational diabetes	3.92e-05	0.00108	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NAMPT—gestational diabetes	3.84e-05	0.00106	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CYP19A1—gestational diabetes	3.84e-05	0.00106	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—GCK—gestational diabetes	3.82e-05	0.00105	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GLS2—gestational diabetes	3.79e-05	0.00104	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—FGF2—gestational diabetes	3.64e-05	0.001	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	3.25e-05	0.000894	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NAMPT—gestational diabetes	3.22e-05	0.000886	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GCK—gestational diabetes	3.2e-05	0.000881	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GGCT—gestational diabetes	3.2e-05	0.00088	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	3.18e-05	0.000875	CbGpPWpGaD
Doxorubicin—NOS2—Disease—FGF2—gestational diabetes	3.13e-05	0.000864	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CYP19A1—gestational diabetes	3.11e-05	0.000857	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NAMPT—gestational diabetes	3.11e-05	0.000857	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GCK—gestational diabetes	3.09e-05	0.000852	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GGCT—gestational diabetes	3.01e-05	0.000829	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CYP19A1—gestational diabetes	2.98e-05	0.000822	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—FGF2—gestational diabetes	2.88e-05	0.000794	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NAMPT—gestational diabetes	2.83e-05	0.00078	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GCK—gestational diabetes	2.81e-05	0.000775	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GLS2—gestational diabetes	2.79e-05	0.000769	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—LEP—gestational diabetes	2.66e-05	0.000732	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GLS2—gestational diabetes	2.63e-05	0.000725	CbGpPWpGaD
Doxorubicin—NOS3—Disease—FGF2—gestational diabetes	2.43e-05	0.00067	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CYP19A1—gestational diabetes	2.34e-05	0.000644	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CYP19A1—gestational diabetes	2.26e-05	0.000623	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—LEP—gestational diabetes	2.24e-05	0.000618	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NAMPT—gestational diabetes	2.08e-05	0.000572	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GCK—gestational diabetes	2.06e-05	0.000568	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CYP19A1—gestational diabetes	2.06e-05	0.000567	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—FGF2—gestational diabetes	2.02e-05	0.000556	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GGCT—gestational diabetes	1.97e-05	0.000542	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	1.94e-05	0.000533	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GLS2—gestational diabetes	1.72e-05	0.000474	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—FGF2—gestational diabetes	1.7e-05	0.00047	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NAMPT—gestational diabetes	1.53e-05	0.000422	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GCK—gestational diabetes	1.52e-05	0.000419	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP19A1—gestational diabetes	1.51e-05	0.000415	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FGF2—gestational diabetes	1.48e-05	0.000409	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NAMPT—gestational diabetes	1.44e-05	0.000397	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GCK—gestational diabetes	1.43e-05	0.000395	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP19A1—gestational diabetes	1.11e-05	0.000306	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP19A1—gestational diabetes	1.05e-05	0.000289	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NAMPT—gestational diabetes	9.43e-06	0.00026	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GCK—gestational diabetes	9.37e-06	0.000258	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP19A1—gestational diabetes	6.85e-06	0.000189	CbGpPWpGaD
